CD-P-PH/PHO - Base de données et publications
base de données melclass
Recommandations sur la classification des médicaments et leurs conditions de délivrance (disponibles dans la base de données MELCLASS)
Examens des classifications fondés sur les preuves
- Evidence-based classification review for Ricinus oleum (2025)
- Evidence-based classification review for Agnus castus fructus (2025)
- Evidence-based classification review for Hedera helix folium (2025)
- Evidence-based classification review for Capsicum (2025)
- Evidence-based classification review for Hypericum herba (2025)
- Evidence-based reviews of medicines belonging to the ATC group D04A and Naloxone (2022)
- Evidence-based reviews of medicines belonging to the ATC groups S01GA and S01GX (2022)
- Evidence-based reviews of medicines belonging to the ATC group R05DA and Doxylamine (2021)
- Evidence-based reviews of medicines belonging to the ATC group R05DB (2021)
- Evidence-based reviews of medicines belonging to the ATC group D07A (2019)
- Evidence-based reviews of medicines belonging to the ATC group N02B (2019)
- Evidence-based reviews of medicines belonging to the ATC group R01 (2019)
- Evidence-based reviews of medicines with various ATC codes (2019)
- Evidence-based reviews of medicines belonging to the ATC group G01AF and Promethazine (2017)
- Evidence-based reviews of medicines belonging to the ATC groups A02BA and A02BC (2016)
Rapports d'enquête
- Rapport d'enquête “National requirements for non-prescription medicines and reclassification of medicines” 2024
- Rapport d'enquête “New trends as regards the supply modes of medicines” 2020
Résultats du programme
Accès en ligne
Pour connaître la classification d’un médicament dans un pays donné ou la recommandation du CD-P-PH/PHO sur le statut de prescription d’un médicament, et les conditions de délivrance qui y sont associées, consultez la base de données Melclass.
Information supplémentaire
